Australian Clinical Labs

AI And Laboratory Automation Will Advance Personalized Testing

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Consensus Narrative from 10 Analysts

Published

09 Feb 25

Updated

27 Aug 25

AnalystConsensusTarget's Fair Value

AU$3.60

27.5% undervalued

27 Aug

AU$2.61

1Y

-21.4%

7D

-3.7%

Loading

1Y

-21.4%

7D

-3.7%

Edit anytime before May 12 6:02 AM. Then post Updates to your followers.

Author's Valuation

AU$3.6

27.5% undervalued

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 3.49%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 0.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.59%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.53%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 1.07%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

AU$3.6

27.5% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

4.21%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

6.48%

Calculation

AU$45.94m

Earnings '28

x

17.12x

PE Ratio '28

=

AU$786.61m

Market Cap '28

AU$786.61m

Market Cap '28

/

181.12m

No. shares '28

=

AU$4.34

Share Price '28

AU$4.34 Share Price '28

Discounted to 2025 @ 6.48% p.a.

=

AU$3.60

Fair Value '25